 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 2002, 22(21):9221-9227
Ciliary Neurotrophic Factor (CNTF) Enhances Myelin Formation:
A Novel Role for CNTF and CNTF-Related Molecules
Bruno
Stankoff1,
Marie-Stéphane
Aigrot1,
Frédéric
Noël1,
Aurélie
Wattilliaux1,
Bernard
Zalc1, and
Catherine
Lubetzki1, 2
1 Biologie des Interactions Neurones-Glie, Institut
National de la Santé et de la Recherche Médicale
Unité 495, Paris cedex 13, France, and
2 Fédération de Neurologie, Université
Pierre et Marie Curie, Hôpital de la Salpêtrière,
75651 Paris cedex 13, France
In multiple sclerosis, myelin repair is generally insufficient
despite the relative survival of oligodendrocytes within the plaques
and the recruitment of oligodendrocyte precursors. Promoting remyelination appears to be a crucial therapeutic challenge. Using a
newly developed enzymatic index of myelination, we screened different
neurotrophic factors for their ability to enhance myelination. Neurotrophins [NGF, neurotrophin-3 (NT-3), NT-4/5, BDNF], glial cell
line-derived neurotrophic factor (GDNF)-related factors (GDNF, neurturin), and growth factors such as PDGF-AA, FGF-2, and
insulin did not increase myelinogenesis. In contrast, among factors
belonging to the CNTF family, CNTF, leukemia inhibitory factor,
cardiotrophin-1, and oncostatin M induced a strong promyelinating
effect. We provide evidence that CNTF acts on oligodendrocytes by
favoring their final maturation, and that this effect is mediated
through the 130 kDa glycoprotein receptor common to the CNTF
family and transduced through the Janus kinase pathway. Our results
demonstrate a novel role for neurotrophic factors of the CNTF family
and raise the possibility that these factors might be of therapeutic
interest to promote remyelination in multiple sclerosis.
Key words:
oligodendrocytes; multiple sclerosis; myelination; remyelination; neurotrophins; growth factors; ciliary neurotrophic
factor
Copyright © 2002 Society for Neuroscience 0270-6474/02/22219221-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Dubois-Dalcq, A. Williams, C. Stadelmann, B. Stankoff, B. Zalc, and C. Lubetzki
From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
Brain,
July 1, 2008;
131(7):
1686 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kuhlmann, L. Remington, I. Cognet, L. Bourbonniere, S. Zehntner, F. Guilhot, A. Herman, A. Guay-Giroux, J. P. Antel, T. Owens, et al.
Continued Administration of Ciliary Neurotrophic Factor Protects Mice from Inflammatory Pathology in Experimental Autoimmune Encephalomyelitis
Am. J. Pathol.,
August 1, 2006;
169(2):
584 - 598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Stark and A. H. Cross
Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis
Int. Immunol.,
February 1, 2006;
18(2):
347 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jaillard, S. Harrison, B. Stankoff, M. S. Aigrot, A. R. Calver, G. Duddy, F. S. Walsh, M. N. Pangalos, N. Arimura, K. Kaibuchi, et al.
Edg8/S1P5: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival
J. Neurosci.,
February 9, 2005;
25(6):
1459 - 1469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zhang, J. Chebath, P. Lonai, and M. Revel
Enhancement of Oligodendrocyte Differentiation from Murine Embryonic Stem Cells by an Activator of gp130 Signaling
Stem Cells,
May 1, 2004;
22(3):
344 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|